|
|
Webinar | Andelyn Biosciences | Hear how one family, driven by urgency, partnered with AAV experts to develop a treatment for their daughter’s ultra-rare neurodegenerative disorder, NEDAMSS, in just 14 months. |
|
|
|
Video | Charter Medical | Watch part 3 of a four-part series to learn about therapy containment/protection studies, and how they project how a therapy will perform at ultra-low temperatures. |
|
|
|
Video | Thermo Fisher Scientific | Uniform bubble size and consistent mass transfer across scales through drilled-hole sparge technology improves oxygen delivery and CO2 stripping in demanding cell culture processes. |
|
|
|
Webinar | MilliporeSigma | Know the differences between designing a viral clearance study for non-enveloped viral vectors versus those for mAbs or recombinant proteins, and learn how to identify and remove viral contaminants. |
|
|
|
Webinar | Lonza | The streamlined AAV transient transfection platform de-risks your path to IND and reduces complexity and timeline for lengthy process and analytical development. |
|
|
|
Webinar | MaxCyte, Inc. | Researchers developed base-edited CAR T cells and CD45-edited stem cells to create universal blood cancer immunotherapy, showcasing efficacy while minimizing toxicity using electroporation technology. |
|
|
|
Video | By Cell & Gene Live | In this final segment of our Cell & Gene Live, Automating Autologous CAR T Manufacturing: Lessons from Mayo Clinic, expert panelists Anthony DeFusco, M.S., Senior Director of Quality Control for the Center for Regenerative Biotherapeutics; Snigdha Rai, M.S., Senior Director of Biomanufacturing; and Cynthia Wilkins, Ph.D., M.B.A., Senior Director of Process Development and Assistant Professor of Regenerative Medicine, Mayo Clinic focused on quality risks during site transfers, including differences in analytical methods, equipment, reagents, reference materials, and software. |
|
|
| Connect With Cell & Gene: |
|
|
|